Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Disease Progression and DHFR[original query] |
|---|
| Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations. The pharmacogenomics journal 2014 Oct 14 (5): 411-7. Corrigan A, Walker J L, Wickramasinghe S, Hernandez M A, Newhouse S J, Folarin A A, Lewis C M, Sanderson J D, Spicer J, Marinaki A |
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
The Lancet. Neurology 2017 Jun . Moss Davina J Hensman, Pardiñas Antonio F, Langbehn Douglas, Lo Kitty, Leavitt Blair R, Roos Raymund, Durr Alexandra, Mead Simon, , , Holmans Peter, Jones Lesley, Tabrizi Sarah |
| MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1. Brain : a journal of neurology 2019 6 142 (7): 1876-86. Flower Michael, Lomeikaite Vilija, Ciosi Marc, Cumming Sarah, Morales Fernando, Lo Kitty, Hensman Moss Davina, Jones Lesley, Holmans Peter, , , Monckton Darren G, Tabrizi Sarah |
| Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates. Molecular cancer therapeutics 2019 Oct . Malhotra Usha, Mukherjee Sarbajit, Fountzilas Christos, Boland Patrick, Miller Austin, Patnaik Santosh, Attwood Kristopher, Yendamuri Sai, Adjei Araba, Kannisto Eric, Opyrchal Mateusz, Bushunow Peter, Loud Peter, Iyer Renuka, Khushalani Nikh |
- Page last reviewed:Feb 1, 2024
- Content source: